The following pages link to Tomasz Burzykowski (Q957032):
Displayed 33 items.
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points (Q87467) (← links)
- Choice of units of analysis and modeling strategies in multilevel hierarchical models (Q957034) (← links)
- Comparison of different estimation procedures for proportional hazards model with random effects (Q1020030) (← links)
- Exploring and validating surrogate endpoints in colorectal cancer (Q1029801) (← links)
- Sequential double cross-validation for assessment of added predictive ability in high-dimensional omic applications (Q1621008) (← links)
- Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials (Q1658329) (← links)
- A hidden Markov-model for gene mapping based on whole-genome next generation sequencing data (Q2258444) (← links)
- A multivariate linear model for investigating the association between gene-module co-expression and a continuous covariate (Q2324984) (← links)
- Simplified modeling strategies for surrogate validation with multivariate failure-time data (Q2445595) (← links)
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (Q2475730) (← links)
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials (Q2792764) (← links)
- An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference (Q2827172) (← links)
- A Cross-Validation Study to Select a Classification Procedure for Clinical Diagnosis Based on Proteomic Mass Spectrometry (Q2864025) (← links)
- Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time (Q2894011) (← links)
- A Markov-Chain Model for the Analysis of High-Resolution Enzymatically 18O-Labeled Mass Spectra (Q2921179) (← links)
- Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints (Q3445296) (← links)
- On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints (Q3465713) (← links)
- Fitting Conditional Survival Models to Meta‐Analytic Data by Using a Transformation Toward Mixed‐Effects Models (Q3530102) (← links)
- Validation of a longitudinally measured surrogate marker for a time-to-event endpoint (Q3591808) (← links)
- A Comparison of Procedures for Controlling the False Discovery Rate in the Presence of Small Variance Genes: A Simulation Study (Q3652748) (← links)
- Simplified hierarchical linear models for the evaluation of surrogate endpoints (Q4432903) (← links)
- The validation of surrogate endpoints in meta-analyses of randomized experiments (Q4489920) (← links)
- Linear Mixed-Effects Models Using R (Q4907714) (← links)
- A Markov-chain-based regression model with random effects for the analysis of<sup>18</sup>O-labelled mass spectra (Q4922618) (← links)
- Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes (Q5121917) (← links)
- A Version of the EM Algorithm for Proportional Hazard Model with Random Effects (Q5122779) (← links)
- Evaluation of Laplace distribution-based ANOVA models applied to microarray data (Q5124814) (← links)
- Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference‐test (Q5283327) (← links)
- A perspective on surrogate endpoints in controlled clinical trials (Q5424596) (← links)
- Using Linear Mixed Models for Normalization of cDNA Microarrays (Q5443045) (← links)
- Testing for Trends in Dose-Response Microarray Experiments: A Comparison of Several Testing Procedures, Multiplicity and Resampling-Based Inference (Q5443064) (← links)
- Performance of Gene Selection and Classification Methods in a Microarray Setting: A Simulation Study (Q5451152) (← links)
- Resampling Plans for Frailty Models (Q5481634) (← links)